Abigail E. Case
Impact in
-
- Acute Myeloid Leukemia Research
- Statistics and Probability top 10%
- Statistical Methods in Clinical Trials
Papers in
-
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 4
- Genetics 3
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Jeremy A. Rassen (1 shared paper)Elizabeth M. Garry (1 shared paper)Chengcheng Meng (6 shared papers)Martin Sattler (6 shared papers)Ellen Weisberg (6 shared papers)Nathanael S. Gray (5 shared papers)Sara J. Buhrlage (5 shared papers)Sophia Adamia (5 shared papers)
- Journals
- Journal of Cellular and Molecular Medicine (2 papers)British Journal of Cancer (2 papers)Blood Cancer Journal (1 paper)Cancers (1 paper)Leukemia (1 paper)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Abigail E. Case
10 papers receiving 327 citations
Peers
Comparison fields: 5 of 78
- Hematology 69
- Statistics and Probability 32
- Genetics 18
- Economics and Econometrics 45
- Cell Biology 27
Countries citing papers authored by Abigail E. Case
This map shows the geographic impact of Abigail E. Case's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abigail E. Case with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abigail E. Case more than expected).
Fields of papers citing papers by Abigail E. Case
This network shows the impact of papers produced by Abigail E. Case. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abigail E. Case. The network helps show where Abigail E. Case may publish in the future.
Co-authors
The 25 scholars most cited alongside Abigail E. Case, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 119 | |
| 2 | 2018 | 47 | |
| 3 | 2019 | 42 | |
| 4 | 2022 | 36 | |
| 5 | 2020 | 27 | |
| 6 | 2020 | 21 | |
| 7 | 2020 | 20 | |
| 8 | 2019 | 12 | |
| 9 | 2021 | 11 | |
| 10 | 2020 | 2 |
About Abigail E. Case
Abigail E. Case is a scholar working on Hematology, Genetics, Neurology, Statistics and Probability and Biotechnology, having authored 10 papers that have together received 337 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Statistical Methods in Clinical Trials (1 paper), Cancer Research and Treatments (1 paper), Advanced Causal Inference Techniques (1 paper), Chromatin Remodeling and Cancer (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Hematology (69 citations), Statistics and Probability (32 citations), Genetics (18 citations), Economics and Econometrics (45 citations) and Cell Biology (27 citations). Abigail E. Case has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Jeremy A. Rassen, Elizabeth M. Garry, Chengcheng Meng, Martin Sattler, Ellen Weisberg, Nathanael S. Gray, Sara J. Buhrlage, Sophia Adamia, Richard Maury Stone and Jinhua Wang. Their work appears in journals such as Journal of Cellular and Molecular Medicine, British Journal of Cancer, Blood Cancer Journal, Cancers and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.